Dynamic Biosensors
Founded 2013 · 57 employees on LinkedIn · 2 known investors
Dynamic Biosensors develops the heliX biosensor instruments and switchSENSE and single-cell Interaction Cytometry (scIC) technologies for characterizing molecule-molecule and molecule-cell interactions and binding kinetics. Its instruments serve researchers in drug discovery and life sciences studying biophysical molecular interactions; the company was acquired by Bruker in 2024.
Investors · 2
Frequently asked questions
- What does Dynamic Biosensors do?
- Dynamic Biosensors develops the heliX biosensor instruments and switchSENSE and single-cell Interaction Cytometry (scIC) technologies for characterizing molecule-molecule and molecule-cell interactions and binding kinetics. Its instruments serve researchers in drug discovery and life sciences studying biophysical molecular interactions; the company was acquired by Bruker in 2024.
- Who are Dynamic Biosensors's investors?
- Dynamic Biosensors's investors include Bayern Kapital, UVC Partners.